...
首页> 外文期刊>The Surgeon >Jass staging is a predictor of outcome following 'curative' resection of Dukes' B colorectal carcinoma
【24h】

Jass staging is a predictor of outcome following 'curative' resection of Dukes' B colorectal carcinoma

机译:Jass分期是杜克B结肠直肠癌“根治性”切除术后预后的指标

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Aims: We have sought to determine if the addition of the Jass pathological classification to Dukes' staging would provide improved prognostic information for patients undergoing curative surgery for Dukes' B colorectal carcinoma. Patients and Methods: One hundred and eighty three patients who underwent curative surgery for Dukes' B colorectal cancers between December 1988 and January 1998 were identified. An assessment of Jass scoring was made at the time of initial histological staging. All patients entered a comprehensive follow-up system. Results: Jass grouping was found to correlate significantly with cancer specific mortality rates; group Ⅲ having a worse prognosis than groups Ⅰ and Ⅱ (p< 0.005). There was no significant difference between either local recurrence or systemic recurrence and the Jass group. Conclusion: The Jass classification provides additional prognostic information in patients following curative resection of Dukes' B colorectal carcinoma and may therefore facilitate the selection of patients who will benefit most from adjuvant treatment.
机译:背景与目的:我们试图确定在Dukes分期中加入Jass病理学分类是否能为接受Dukes B大肠癌根治性手术的患者提供更好的预后信息。患者和方法:确定了1988年12月至1998年1月间接受过Dukes'B结肠直肠癌根治性手术的183例患者。在最初的组织学分期时评估Jass评分。所有患者均进入了全面的随访系统。结果:Jass分组被发现与癌症的特定死亡率显着相关。 Ⅲ组的预后比Ⅰ,Ⅱ组差(p <0.005)。局部复发或全身性复发与Jass组之间无显着差异。结论:Jass分类为Dukes'B大肠癌的根治性切除术后的患者提供了更多的预后信息,因此可能有助于选择将从辅助治疗中受益最大的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号